Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.23050
Abstract: Atrial fibrillation (AF) is a common complication in patients with hypertrophic cardiomyopathy (HCM) and may contribute to high cardiovascular morbidity and mortality. Therefore, it is important to assess parameters associated with AF in HCM patients. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13964
Abstract: To describe the natural history of SARS‐CoV‐2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13983
Abstract: We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for a follow‐up period of more than 10 years. read more here.
Sign Up to like & get recommendations! 2
Published in 2020 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2020.03.030
Abstract: BACKGROUND Positive T wave in lead aVR (TaVR) has been associated with increased risk of adverse events in various cardiovascular diseases. OBJECTIVE We aimed to investigate the prevalence and prognostic significance of positive TaVR in… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2020.07.036
Abstract: BACKGROUND Despite numerous studies assessing the natural history of patients with hypertrophic cardiomyopathy (HCM), there is lack of data regarding the burden of hospitalization. Aim of this study was to describe prevalence, causes and predictors… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Arrhythmia"
DOI: 10.1016/j.joa.2016.08.006
Abstract: Radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) refractory to medical therapy remains controversial in patients with hypertrophic cardiomyopathy (HCM); the acute effects on the direct left atrial (LA) pressure are not completely understood. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)30891-x
Abstract: Approximately 1 in 5 patients with hypertrophic obstructive cardiomyopathy (HOCM) have atrial fibrillation (AF) and HOCM patients with AF are at increased risk of heart failure-exacerbation and hospitalization. However, it is still unclear if pulmonary… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32183-1
Abstract: Adult patients with hypertrophic cardiomyopathy (HCM) have a high risk of sudden cardiac death related to the degree of fibrosis quantified by cardiac MRI (CMR). The interaction between myocardial mechanics and fibrosis has not been… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)31477-9
Abstract: Significant left ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy (HCM) may result in symptoms and is associated with adverse outcomes. Although disopyramide can reduce resting gradients through its negative inotropic properties, nearly one third… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.0010
Abstract: Exercise echocardiography (ExE) may assess left ventricular (LV) systolic and diastolic function, LV outflow tract (LVOT) obstruction and mitral regurgitation (MR). We aimed to assess the feasibility and prognostic value of the assessment of all… read more here.